Fisiología y fisiopatología vascular y del tracto urinario
Hospital Alemão Oswaldo Cruz
São Paulo, BrasilPublicaciones en colaboración con investigadores/as de Hospital Alemão Oswaldo Cruz (4)
2024
-
Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial
The Lancet Global Health, Vol. 12, Núm. 2, pp. e257-e270
2022
-
Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination
Journal of Infectious Diseases, Vol. 225, Núm. 9, pp. 1521-1532
-
Three-year Efficacy and Safety of Takeda's Dengue Vaccine Candidate (TAK-003)
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 75, Núm. 1, pp. 107-117
2020
-
Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial
The Lancet, Vol. 395, Núm. 10234, pp. 1423-1433